
Quris is an artificial intelligence innovator disrupting the drug development process with its Bio-AI Clinical Prediction Platform. This platform predicts which drug candidates will safely work in humans, significantly reducing the costs associated with failed clinical trials. Led by a team of top scientists and strategic investors, Quris is preparing for clinical testing with its first AI-based drug. The company aims to address the trillion-dollar challenge of drug development by utilizing a unique machine-learning approach that generates data through miniaturized Patients-on-a-Chip, making it a leader in the pharmaceutical AI space.

Quris is an artificial intelligence innovator disrupting the drug development process with its Bio-AI Clinical Prediction Platform. This platform predicts which drug candidates will safely work in humans, significantly reducing the costs associated with failed clinical trials. Led by a team of top scientists and strategic investors, Quris is preparing for clinical testing with its first AI-based drug. The company aims to address the trillion-dollar challenge of drug development by utilizing a unique machine-learning approach that generates data through miniaturized Patients-on-a-Chip, making it a leader in the pharmaceutical AI space.